Jennifer Lew, Chief Financial Officer at ADURO BIOTECH, INC. (ADRO), sold 1,035 shares at $2.93 ($3K) on 2018-12-12, disclosed to the SEC on 2018-12-14.
Open-market sale of $3k ADRO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ANNX | SELL | 2025-07-16 | $3K | — | Filing → |
| ANNX | SELL | 2025-02-20 | $20K | — | Filing → |
| ANNX | SELL | 2025-02-18 | $5K | — | Filing → |